Penelope Markham - Aug 20, 2021 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
EVP Liver Cirrhosis R&D
Signature
/s/ Joanne Wendy Kim as Attorney-In-Fact
Stock symbol
BIVI
Transactions as of
Aug 20, 2021
Transactions value $
$0
Form type
4
Date filed
9/16/2021, 12:52 PM
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 -124K -50% $0.00 124K Aug 20, 2021 Common Stock 124K $7.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney